Galmed Pharmaceuticals Sets Shareholder Meeting for Oct 14
Ticker: GLMD · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Sep 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Galmed calling shareholder meeting Oct 14 - expect votes on key company moves.
AI Summary
Galmed Pharmaceuticals Ltd. announced on September 20, 2024, that it will hold a Special General Meeting of Shareholders on Monday, October 14, 2024, at 5:00 p.m. Israel time. The meeting will take place at the offices of Meitar Law Offices in Ramat Gan, Israel. Shareholders will receive a Notice of the Special General Meeting, Proxy Statement, and Proxy Card.
Why It Matters
This meeting is a crucial step for Galmed to potentially make significant corporate decisions that could impact its future direction and shareholder value.
Risk Assessment
Risk Level: low — The filing is an administrative announcement of a shareholder meeting, not a financial event or strategic shift.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Registrant
- October 14, 2024 (date) — Special General Meeting date
- Meitar Law Offices (company) — Legal counsel and meeting location
- Ramat Gan, Israel (location) — Address of principal executive offices and meeting location
FAQ
What is the purpose of the Special General Meeting of Shareholders?
The filing does not specify the exact agenda items for the Special General Meeting, only that a Notice and Proxy Statement will be provided.
When and where will the Special General Meeting be held?
The meeting is scheduled for Monday, October 14, 2024, at 5:00 p.m. Israel time, at the offices of Meitar Law Offices in Ramat Gan, Israel.
Who is providing legal counsel to Galmed Pharmaceuticals Ltd. for this meeting?
Meitar Law Offices is serving as the legal counsel to the Company.
What documents will shareholders receive regarding the meeting?
Shareholders will receive a Notice of the Special General Meeting of Shareholders, a Proxy Statement, and a Proxy Card.
Is this Galmed's first report of this nature for September 2024?
The filing is designated as 'Report No. 2' for the month of September 2024.
Filing Stats: 282 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2024-09-20 16:46:04
Filing Documents
- form6-k.htm (6-K) — 19KB
- ex99-1.htm (EX-99.1) — 38KB
- ex99-2.htm (EX-99.2) — 22KB
- ex99-2_002.jpg (GRAPHIC) — 1KB
- image_001.jpg (GRAPHIC) — 1KB
- 0001493152-24-037628.txt ( ) — 83KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Galmed Pharmaceuticals Ltd. Date: September 20, 2024 By: /s/ Allen Baharaff Allen Baharaff President and Chief Executive Officer